Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
Products
Automate
Trackers
Innovation Services
About Index
Index
By TNW
Log in
Register
Forbion Capital Partners
1202
Forbion Capital Partners
Forbion Capital Partners invests in Life Sciences and Biomedical Technology companies developing worldclass drugs and technologies, with a clear focus on product development..
Suggest edits
Type
B2b
Founded
2007
Follow us
Companies in the same industry
Albion Capital
Charlesbank Capital Partners
Five Arrows Principal Investments
Beyond Ventures
Trive Capital
Kinara Capital
Generate Capital
Robo Global Robotics & Automation
Olympus Partners
Aeris Partners
Overview
News
Investments
24
Portfolio
Portfolio Tracker
Add info
Add round
03 Jun
2020
Prilenia
$62,500,000
Venture capital (Series A)
Forbion Capital Partners
,
Sectoral Asset Management
,
Morningside Venture Investments
,
+1
Prilenia Therapeutics Raises $62.5M in Series A Funding
FinSMEs
18 Feb
2020
Azafaros
€25,000,000
Venture capital (Series A)
BioMedPartners
,
Forbion Capital Partners
,
BioGeneration Ventures
Azafaros Closes €25M Series A Financing
FinSMEs
03 Apr
2019
Dyne Therapeutics
$50,000,000
Venture capital (Series A)
MPM Capital
,
Forbion Capital Partners
29 Aug
2018
KaNDy Therapeutics
£25,000,000
Venture capital (Series C)
Fountain Healthcare Partners
,
OrbiMed
,
Forbion Capital Partners
,
+2
KaNDy Therapeutics Raises £25M in Series C Financing
FinSMEs
+2
12 Dec
2017
NorthSea Therapeutics
€25,000,000
Venture capital (Series A)
New Science Ventures
,
Forbion Capital Partners
,
BioGeneration Ventures
,
+1
11 Dec
2017
Hookipa Pharma
$59,600,000
Venture capital (Series C)
Sofinnova Partners
,
BioMedPartners
,
Forbion Capital Partners
,
+6
| Hookipa Biotech scores $59.6 mln Series C
PE HUB
01 Aug
2017
Milestone Pharmaceuticals, Inc.
$55,000,000
Venture capital (Series C)
Fonds de solidarité FTQ
,
Domain Associates
,
BDC Capital
,
+5
Milestone Pharmaceuticals Closes $55 Million Series C Financing
prnewswire
24 Jul
2017
Exosome Diagnostics
$30,000,000
Venture capital (Series C)
CD-Venture
,
Arcus Ventures
,
NGN Capital
,
+4
citybizlist : Exosome Diagnostics Raises $30M Series C
citybizlist
07 Feb
2017
Prexton Therapeutics SA
€29,000,000
Venture capital (Series B)
Sunstone Capital
,
Seroba Kernel
,
Forbion Capital Partners
,
+2
Prexton Therapeutics, participated by Ysios Capital, Series B financing round raises € 29 millions to advance its novel Parkinson’s therapeutic.es
capital-riesgo
+1
05 Jan
2017
NeRRe Therapeutics
£23,000,000
Venture capital (Series B)
Fountain Healthcare Partners
,
OrbiMed
,
Novo A/S
,
+2
NeRRE Therapeutics picks up Series B funds
PE Hub
+2
06 Sep
2016
Rigontec GmbH
€15,000,000
Venture capital (Series A)
High-Tech Gruenderfonds
,
Sunstone Capital
,
MP Healthcare Venture Management
,
+3
Rigontec Raises €15M in Third Closing of Series A Funding
FinSMEs
15 Jun
2016
Allecra Therapeutics
€22,000,000
Venture capital (Series B)
EMBL Ventures
,
Forbion Capital Partners
,
Edmond de Rothschild Investment Partners
,
+2
Allecra Therapeutics Announces €22 Million Series B Financing
prnewswire
+1
16 Feb
2016
Akarna Therapeutics
$15,000,000
Venture capital (Series B)
New Science Ventures
,
Third Point Ventures
,
Forbion Capital Partners
Akarna Therapeutics Closes $15M Series B Financing
FinSMEs
07 Jan
2016
Exosome Diagnostics
$60,000,000
Venture capital (Series B)
Tiger Management
,
Qiagen
,
Arcus Ventures
,
+4
Exosome Diagnostics Completes $60 Million Series B Financing
businesswire
+2
02 Sep
2015
Exosome Diagnostics
$17,600,000
Venture capital (Series B)
Tiger Management
,
CD-Venture
,
Arcus Ventures
,
+2
Exosome Diagnostics Raises $17.6 Million in Second Round Series B Financing
BioPortfolio
11 Mar
2014
Exosome Diagnostics
$27,000,000
Venture capital (Series B)
b-to-v Partners AG
,
Qiagen
,
Arcus Ventures
,
+2
Exosome Diagnostics raises USD 27m in Series B Financing Partners AG
b-to-v
+1
25 Jul
2012
bluebird bio
$60,000,000
Venture capital (Series D)
RA Capital Management
,
ARCH Venture Partners
,
Third Rock Ventures
,
+4
20 Apr
2011
bluebird bio
$30,000,000
Venture capital
Easton Capital
,
ARCH Venture Partners
,
Third Rock Ventures
,
+2
04 Feb
2011
Cellnovo
$48,268,413
Venture capital (Series B)
Advent Venture Partners
,
Auriga Partners
,
Crédit Agricole Private Equity
,
+5
04 Jan
2011
PneumRx, Inc., a BTG International group company
$33,000,000
Venture capital
Adams Street Partners
,
Endeavour Vision
,
Leader Ventures
,
+5